Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab-paclitaxel chemotherapy: A multicenter retrospective cohort study (PC-CURE-1)
FOLFIRINOX 或吉西他滨加白蛋白紫杉醇化疗后接受转化手术的初始不可切除胰腺癌患者的预后:一项多中心回顾性队列研究 (PC-CURE-1)
期刊:Journal of Hepato-Biliary-Pancreatic Sciences
影响因子:2.8
doi:10.1002/jhbp.12066
Okano, Naohiro; Kawai, Manabu; Ueno, Makoto; Yu, Xianjun; Inoue, Yosuke; Takahashi, Shinichiro; Wang, Wenquan; Takahashi, Hidenori; Okamura, Yukiyasu; Morinaga, Soichiro; Matsumoto, Ippei; Shimizu, Yasuhiro; Yoshida, Kazuhiro; Yamamoto, Tomohisa; Ohtsuka, Masayuki; Inokawa, Yoshikuni; Nara, Satoshi; Tamura, Jun; Shinoda, Satoru; Yamamoto, Kouji; Yamaue, Hiroki; Furuse, Junji